Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
11/2005
11/24/2005US20050261425 Multiblock copolymers having improved mechanical properties
11/24/2005US20050261196 Comprising nonapeptide wherein first three amino acids and last three amino acids of sequence comprise basic amino acids, and wherein inhibitor comprises at least one D-amino acid or at least one non-hydrolyzable bond; may be used to treat intestinal diseases; infectious, ischemic, inflammatory disease
11/24/2005US20050261195 Process for preparing LH-RH derivatives
11/24/2005US20050261194 Use of thymulin-like peptides for making pain-relieving medicines
11/24/2005US20050261193 Antimicrobial theta defensins and methods of using same
11/24/2005US20050261177 Compound
11/24/2005US20050261172 Peptide for increasing bone density; peptide is glycosylated, is 4 amino acids in length; the amino acid sequence consists of a sequence identical to the first 4 consecutive amino acids
11/24/2005US20050261169 Peptide and peptide mimetic derivatives having integrin inhibitor properties III
11/24/2005US20050260587 Synthetic transfer complex and method for transferring nucleic acids
11/24/2005CA2565872A1 T-cell death-inducing epitopes
11/24/2005CA2562576A1 Cyclopeptide derivatives with anti-integrin activity
11/24/2005CA2560981A1 Polymer-based sustained release device
11/23/2005EP1598369A1 Antibody and use thereof
11/23/2005EP1598365A1 Protection of endogenous therapeutic peptides
11/23/2005EP1597270A2 Peptidomimetic inhibitors of stat3 activity and their medical uses
11/23/2005EP1597265A2 Glycosolated enkephalin agents
11/23/2005EP1596879A1 Use of kahalalide compounds for the manufacture of a medicament for the treatment of psoriasis
11/23/2005EP0770129B1 Zinc finger protein derivatives and methods therefor
11/23/2005EP0732934B1 Long-acting injection suspensions of an lhrh analogue and a process for their preparation
11/23/2005CN1699409A Active fragment of human glycine-rich protein and use thereof
11/23/2005CN1699408A Peptide for high performance inhibition of angiogenesis and method for preparing same and use thereof
11/23/2005CN1698881A Long lasting fusion peptide inhibitors of viral infection
11/23/2005CN1228346C Short peptide and its derivative and medicine with them as active component and use thereof
11/22/2005US6967240 proteinaceous compound or functionally active derivative thereof having a binding site for a group of toxins derived from various cyanobacteria, to a method for its production, diagnostic kits, and affinty matrix for use in immunoaffinity column
11/22/2005US6967238 Compounds and methods for modulating cell adhesion
11/22/2005US6967237 For use in stimulating growth hormone secretion
11/22/2005US6967192 Seventeen amino acid peptide (Peptide P) for treating ischemia and reperfusion injury
11/17/2005WO2005108432A2 Cd80 (b7-1) binding peptides and uses thereof
11/17/2005WO2005108417A1 Polymeric primer for sugar peptide synthesis
11/17/2005WO2005108416A2 Myosin light chain kinase inhibitors and their use
11/17/2005WO2005107789A1 Use of delta pkc peptides for modulation of reactive oxigen species
11/17/2005WO2005107357A2 Analgesic peptides derived from the venom of crotalus durissus terrificuss snakes
11/17/2005WO2004005318A3 Peptides comprising aromatic d-amino acids and methods of use
11/17/2005US20050257284 Method for producing transgenic plants resistant to weed control compounds which disrupt the porphyrin pathways of plants
11/17/2005US20050256304 Modified factor VIII
11/17/2005US20050256056 Peptide inhibitors of HIV
11/17/2005US20050256049 Chimeric toxins for targeted therapy
11/17/2005US20050256046 obtaining a sequence-defined molecular weight markers that provide an accurate and robust calibration set for determinations of molecular weight of production batches; subjecting the molecular weight markers to column chromatography to establish a relationship between retention time and molecular weight
11/17/2005US20050256034 Dioxolane analogs for improved inter-cellular delivery
11/17/2005US20050255102 binds to alpha v beta 6 and not other alpha v integrins or non-specific integrins; inhibits the binding of alpha v beta 6 to latency associated peptide with an IC50 value lower than that of 10D5 and binds alpha v beta 6 in manner that does not distinguish between the use of Ca2+/Mg2+ and Mn2+ for cation
11/17/2005US20050255101 Antibody having a t-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
11/17/2005US20050255038 Conjugates comprising cancer cell specific ligands, a sugar and diagnostic agents and uses thereof
11/17/2005CA2565731A1 Analog compounds of analgesic peptides derived from the venom of crotalus durissus terrificus snakes, their uses, compositions, methods of preparation and purification
11/17/2005CA2563508A1 Myosin light chain kinase inhibitors and methods of use
11/16/2005EP1595890A2 Synthetic peptide inhibitors of HIV transmission
11/16/2005EP1595889A1 Method of eliminating phosphate group of peptide and method of analyzing peptide
11/16/2005EP1594521A2 Peptides which inhibit angiogenesis, cell migration, cell invasion and cell proliferation, compositions and uses thereof
11/16/2005EP1594517A2 Methods and compositions for the treatment of gastrointestinal disorders
11/16/2005EP1594434A2 Parenteral formulations of peptides for the treatment of systemic lupus erythematosus
11/16/2005EP1294927B1 Screening-method for modulators of methyltransferase-dependent chromosome stability
11/16/2005EP0477295B2 Platelet aggregation inhibitors
11/16/2005CN1227264C Immunogenic peptides derived from MAGE and use thereof
11/15/2005US6965024 Reactive with ganglioside GD3; cancer treatment
11/15/2005US6964766 Peptides for use in immunotherapy of autoimmune diseases
11/15/2005CA2302360C Fluorination of proteins and peptides for f-18 positron emission tomography
11/10/2005WO2005105993A1 Hla-binding peptide, precursor thereof, dna fragment encoding the same and recombinant vector
11/10/2005WO2005105832A2 Biologically active peptide vapeehptllteaplnpk derivatives
11/10/2005WO2005105831A1 Antimicrobial polypeptides
11/10/2005WO2005105830A1 Interleukin-1 receptor antagonists, compositions, and methods of treatment
11/10/2005WO2005105829A2 Caspase-2 inhibitors and their biological applications
11/10/2005WO2005105144A1 LATENT TGF-β ACTIVATION INHIBITOR
11/10/2005WO2005051327A3 Glycopegylated erythropoietin
11/10/2005WO2005037860A3 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
11/10/2005WO2005024058A3 Compounds for the treatment of diseases involving cognitive impairment, such as alzheimer’s disease, and methods for identifying such compounds
11/10/2005WO2004063963A3 Novel proteins with altered immunogenicity
11/10/2005US20050250717 Chromatin remodeling protein as a marker expressed by stromal progenitor cells
11/10/2005US20050250700 KDR and VEGF/KDR binding peptides
11/10/2005US20050250699 Antimicrobial polypeptides
11/10/2005US20050250110 PNA conjugate for treating chronic myeloid leukemia (CML)
11/10/2005US20050249750 Universal T-cell epitopes for anti-malarial vaccines
11/10/2005US20050249743 Isolated peptides which bind to HLA-A24 molecules and uses thereof
11/10/2005CA2607113A1 Interleukin-1 receptor antagonists, compositions, and methods of treatment
11/10/2005CA2564179A1 Biologically active peptide vapeehptllteaplnpk derivatives
11/10/2005CA2564177A1 Caspase-2 inhibitors and their biological applications
11/09/2005EP1593686A1 Antineoplastic peptides
11/09/2005EP1593685A1 Peptide antioxidants from soy protein
11/09/2005EP1592704A2 Leukocyte stimulating peptides
11/09/2005EP1592434A1 Conformationally constrained parathyroid hormone (pth) analogs with lactam bridges
11/09/2005EP1409531B1 Heterocarpine, a human ghrh-binding protein
11/09/2005EP1068303B1 Peptide for use in the diagnosis of schizophrenia
11/09/2005EP0808330B1 A process for preparing certain aza cyclohexapeptides
11/09/2005CN1694895A Modified transferrin-antibody fusion proteins
11/09/2005CN1694719A Casein derived peptides and uses thereof in therapy
11/08/2005US6962974 non-Goodpasture fragments/domains for binding integrins/endothelial cells, and inhibiting proliferation of tumors/endothelial cells
11/08/2005US6962970 Glycopeptide derivatives and pharmaceutical compositions containing the same
11/08/2005US6962934 Such as N-((2S)-2-((3-((dipropylamino)carbonyl)-benzoyl) amino)-3-phenylpropyl)-L-alanyl-N1-isobutyl-L-valinamide; secretase inhibitors
11/08/2005US6962904 Elastin peptide analogs and uses thereof
11/08/2005US6962792 cyclin-dependent kinase 4 (CDK4); useful in treatment of tumours and other hyperproliferative disorders
11/03/2005WO2005103259A1 Sars-cov nucleocapsid protein epitopes and uses thereof
11/03/2005WO2005103072A1 Convergent synthesis for kahalalide compounds
11/03/2005WO2005103071A1 Peptide inhibitors of metalloproteinase activity
11/03/2005WO2005038000A3 T cell epitopes useful in mycobacterium tuberculosis vaccine and as diagnostic tools and methods for identifying same
11/03/2005WO2003074551A8 Conjugates of therapeutic or cytotoxic agents and biologically active peptides
11/03/2005WO2003068168A3 Helical peptidomimetics and use b-amyloid-associated diseases
11/03/2005US20050245726 Detecting the phosphorylation activity of protein kinases using a substrate compound with hydrophobic moieties that integrate the compound into a micelle, non-proteinaceous fluorescent moieties (fluorescent dyes), and an enzyme recognition moiety
11/03/2005US20050245455 Gonadotropin releasing hormone antagonists in gel-forming concentrations
11/03/2005US20050245454 Methods and compositions for impairing multiplication of HIV-1
11/03/2005US20050245453 Peptides derived from cadherin and methods of use thereof
11/03/2005US20050245452 Pharmaceutical use of novispirins
11/03/2005US20050245451 Peptides selectively lethal to malignant and transformed mammalian cells
1 ... 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 ... 423